Cardiovascular Disease Doctors in West Haven, CT Accepting Medicare

5 Cardiovascular Disease doctors found. Showing 1 - 5

Parul U Gandhi, MD Internal Medicine - Cardiovascular Disease Medicare: Not Enrolled in Medicare Practice Location: 950 Campbell Ave, West Haven, CT 06516 Phone: 203-932-5711

Dr. Brian Joseph Malm, M.D. Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 950 Campbell Ave, West Haven, CT 06516 Phone: 203-932-5711    Fax: 203-937-3884

Mark A. Casey, MD Internal Medicine - Cardiovascular Disease Medicare: Not Enrolled in Medicare Practice Location: 950 Campbell Ave, West Haven, CT 06516 Phone: 203-932-5711

Dr. Theresa A Molisse, M.D. Internal Medicine - Cardiovascular Disease Medicare: Not Enrolled in Medicare Practice Location: 950 Campbell Ave, West Haven, CT 06516 Phone: 203-932-5711

Dr. Mehran M Sadeghi, M.D. Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 950 Campbell Ave, West Haven, CT 06516 Phone: 203-932-5711    Fax: 203-937-3884

News Archive

'Obamacare' plays starring role in first night of convention (video)

This collection of Kaiser Health News video excerpts show clips in which several speakers cited the 2010 health law as a signature achievement of the Obama administration Tuesday night at the Democratic National Convention in Charlotte, N.C.

Janssen reports positive pivotal Phase 2 study data of siltuximab for Multicentric Castleman's Disease

Janssen Research & Development, LLC today announced positive results from a pivotal Phase 2 global registration study (MCD2001) suggesting siltuximab, an investigational compound, along with best supportive care, exhibited statistically significant efficacy and a tolerable safety profile compared with placebo and BSC in treating patients with the rare disorder Multicentric Castleman's Disease who are HIV-negative and human herpes virus 8-negative.

ImmunoCellular, Novella partner to conduct ICT-107 phase 3 registration trial in patients with glioblastoma

ImmunoCellular Therapeutics, Ltd. today announced the establishment of an agreement with Novella Clinical (Novella), to conduct the phase 3 registration trial of ICT-107 in patients with newly diagnosed glioblastoma. Novella is a full-service, global clinical research organization (CRO) providing clinical trial services to small to mid-sized oncology companies.

Clinical data from investigational study of patients with multiple myeloma presented at ASCO

Celgene International Sàrl announced clinical data from an investigational study of patients with multiple myeloma who were younger than 65 years old and received either lenalidomide (REVLIMID), melphalan and prednisone or melphalan plus autologous stem cell transplant (MEL200) following an induction treatment of lenalidomide plus low-dose dexamethasone (Rd) were presented at the American Society of Clinical Oncology annual meeting.

NIIT Technologies forays into US health care segment with acquisition of Preferr EHR

NIIT Technologies Limited, a leading IT solutions organization has acquired an electronic health records and referral management platform to initiate its foray into the lucrative health care segment in the US. The platform called "Preferr" (Patient Referral System)" enables seamless collaboration between all providers namely physicians, hospitals, diagnostic facilities, and laboratories.

Read more Medical News

› Verified 7 days ago